Holen Sie sich die Stockscreener-App
22.36
1.97%
-0.45
Handel nachbörslich:
22.36
Schlusskurs vom Vortag:
$22.81
Offen:
$22.57
24-Stunden-Volumen:
244.19K
Relative Volume:
0.53
Marktkapitalisierung:
$648.63M
Einnahmen:
$219.79M
Nettoeinkommen (Verlust:
$-57.47M
KGV:
-10.40
EPS:
-2.15
Netto-Cashflow:
$-19.25M
1W Leistung:
-2.44%
1M Leistung:
+4.39%
6M Leistung:
+12.42%
1J Leistung:
-34.73%
1-Tages-Spanne:
$22.23
$22.79
1-Wochen-Bereich:
$22.23
$24.00
52-Wochen-Spanne:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
Firmenname
Castle Biosciences Inc
Sektor
Branche
Telefon
866-788-9007
Adresse
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Vergleichen Sie CSTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
22.36 | 669.51M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
525.83 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.15 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
636.91 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.04 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.76 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-04-30 | Eingeleitet | Lake Street | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Bestätigt | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | BTIG Research | Buy |
| 2019-08-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
Using data tools to time your Castle Biosciences Inc. exitWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
How high can Castle Biosciences Inc. stock go2025 Retail Activity & Verified Entry Point Signals - newser.com
Is Castle Biosciences Inc. stock attractive for income investorsJuly 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Castle Biosciences to Release Third Quarter 2025 Financial - GlobeNewswire
Will Castle Biosciences Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Risk adjusted return profile for Castle Biosciences Inc. analyzedGDP Growth & Weekly Market Pulse Alerts - newser.com
When is the best time to exit Castle Biosciences Inc.Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Castle Biosciences, Inc. to Announce Third Quarter 2025 Financial Results on November 3 - Quiver Quantitative
Nov. 3 webcast: Castle Biosciences to release Q3 results and host conference call at 4:30 PM ET - Stock Titan
Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025 - Sahm
New Data Demonstrates Significant & Risk-Appropriate Clinical Impact of DecisionDx-SCC Test Results on Patient Management Dec... - ADVFN
Is Castle Biosciences Inc. stock poised for growthDividend Hike & Proven Capital Preservation Tips - newser.com
Is this a good reentry point in Castle Biosciences Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What drives Castle Biosciences Inc stock priceCup and Handle Formations & Free Expert Stock Watchlists - earlytimes.in
How to integrate Castle Biosciences Inc. into portfolio analysis toolsMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Castle Biosciences (NASDAQ:CSTL) - MarketBeat
Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Castle Biosciences CEO Maetzold sells $30,234 in shares - Investing.com
Will Castle Biosciences Inc. stock pay special dividendsGDP Growth & Weekly Top Gainers Trade List - newser.com
How Castle Biosciences Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Order flow analysis tools used on Castle Biosciences Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com
Analyzing net buyer seller activity in Castle Biosciences Inc.Trade Volume Summary & Verified Technical Trade Signals - newser.com
Is Castle Biosciences Inc a good long term investmentBollinger Bands Signals & Low Risk Investment Growth - earlytimes.in
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - The Manila Times
Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire
Selected from 586 Executives: Castle Biosciences' Derek Maetzold Crowned CEO of the Year 2025 - Stock Titan
User - FinancialContent
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What analysts say about Castle Biosciences Inc stockSmall Cap Stock Opportunities & High Profit Market Tips - Early Times
Strs Ohio Takes $366,000 Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - markets.businessinsider.com
SciBase Receives Initial Order for Clinical Study From Castle Biosciences - 富途牛牛
Castle Biosciences (NASDAQ:CSTL) Insider Sells $29,417.83 in Stock - MarketBeat
Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):